| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |